|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/46 | (2006.01) |
| A61K 31/506 | (2013.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61K 31/4748 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61K 31/46 | (2013.01) | ||
| A61K 31/4748 | (2006.01) | ||
| A61K 31/497 | (2013.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61K 31/506 | (2006.01) |
| (11) | Number of the document | 3419623 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17707959.7 |
| Date of filing the European patent application | 2017-02-17 | |
| (97) | Date of publication of the European application | 2019-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2017/050912 |
| Date | 2017-02-17 |
| (87) | Number | WO 2017/145031 |
| Date | 2017-08-31 |
| (30) | Number | Date | Country code |
| 201662298117 P | 2016-02-22 | US | |
| 201662420702 P | 2016-11-11 | US |
| (72) |
LAFFITTE, Bryan , US
BADMAN, Michael , US
CHEN, Jin , US
LINDGREN, Sam , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | METHODS FOR USING FXR AGONISTS |
| METHODS FOR USING FXR AGONISTS |